CIK 0001659617 · Non-accelerated filer<br>Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474671997
- Phone
- 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +10,000 | 26,668 | ||
| 2021-06-07 | Cermak Elizabeth Director | Grant or award · Stock option (right to buy) | +10,000 | 16,667 | ||
| 2021-06-07 | Climaco John M Director | Grant or award · Stock option (right to buy) | +10,000 | 24,168 | ||
| 2021-06-07 | George Robert E. Director | Grant or award · Stock option (right to buy) | +10,000 | 26,668 | ||
| 2020-10-02 | Cermak Elizabeth Director | Grant or award · Stock option (right to buy) | +40,000 | 40,000 | ||
| 2020-08-20 | Priebe Waldemar 10% owner | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-07-13 | KLEMP WALTER V CEO and President | Option exercise | +79,227 | 1,046,951 | ||
| 2020-07-13 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −19,292 | $0.86 | $17K | 1,027,659 |
| 2020-07-13 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −79,227 | 2,430,891 | ||
| 2020-07-02 | KLEMP WALTER V CEO and President | Grant or award · Stock option (right to buy) | +500,000 | 2,156,907 | ||
| 2020-07-02 | KLEMP WALTER V CEO and President | Grant or award · Restricted Stock Units | +353,211 | 2,510,118 | ||
| 2020-07-02 | Foster Jonathan P. Exec. Vice President and CFO | Grant or award · Stock option (right to buy) | +460,000 | 1,621,000 | ||
| 2020-07-02 | PICKER DONALD H Chief Science Officer | Grant or award · Stock option (right to buy) | +100,000 | 335,000 | ||
| 2020-06-15 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +15,000 | 100,000 | ||
| 2020-06-15 | Climaco John M Director | Grant or award · Stock option (right to buy) | +15,000 | 85,000 | ||
| 2020-06-15 | George Robert E. Director | Grant or award · Stock option (right to buy) | +15,000 | 100,000 |
Page 12 of 12 · 236 trades